# Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease

> **NCT02243982** · EARLY_PHASE1 · COMPLETED · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 28 (actual)

## Conditions studied

- Parkinson's Disease
- Parkinson-Dementia Syndrome

## Interventions

- **OTHER:** [F18]-FDDNP

## Key facts

- **NCT ID:** NCT02243982
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-06
- **Final completion:** 2012-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243982, "Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02243982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*